Targeted Gene Panels; Centralized Stroke Care; Ocrelizumab and PPMS
MedPage Today,
Targeted gene panels may be an efficient, cost-effective way to diagnose patients with movement disorders.
Targeted gene panels may be an efficient, cost-effective way to diagnose patients with movement disorders.
NEW YORK (GenomeWeb) – Targeted gene panels could offer a cost-effective approach for the diagnosis of movement disorders.
NEW YORK (GenomeWeb) – Targeted gene panels could offer a cost-effective approach for the diagnosis of movement disorders.